Statements (13)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:ATCCode |
none
|
gptkbp:CASNumber |
none
|
gptkbp:clinicalTrialPhase |
Phase 3
|
gptkbp:developedBy |
gptkb:Portola_Pharmaceuticals
|
gptkbp:hasTherapeuticUse |
gptkb:pemphigus_vulgaris
autoimmune diseases |
https://www.w3.org/2000/01/rdf-schema#label |
PRN1008
|
gptkbp:legalStatus |
investigational
|
gptkbp:mechanismOfAction |
Bruton's tyrosine kinase inhibitor
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:bfsParent |
gptkb:Principia_Biopharma
|
gptkbp:bfsLayer |
7
|